Despite the ability of DUX4 to facilitate cancer progression, cancer risk in FSHD is not elevated above that of the general population [35], though recent findings suggest that gastrointestinal cancers in particular may be more prevalent among FSHD adults (>40 years) than in non-affected adults [36]. This evidence concerns the gene DUX4 and facioscapulohumeral muscular dystrophy.